Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT-Reference-Cited by-同舟云学术

Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT

Published:2003-02 Issue:4 Volume:65 Page:657-667
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Wroblewski Victor J,Witcher Derrick R,Becker Gerald W,Davis Kelly A,Dou Shenshen,Micanovic Radmila,Newton Christy M,Noblitt Timothy W,Richardson John M,Song Ho Yeong,Hale John E

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference29 articles.

1. Tumor necrosis factor receptor superfamily members and their ligands;Armitage;Curr. Opin. Immunol.,1994

2. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death;Smith;Cell,1994

3. Nerve growth factor is an autocrine survival factor for memory B lymphocytes;Torcia;Cell,1996

4. Regulation of apoptosis in the immune system;Kramer;Curr. Opin. Immunol.,1994

5. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis;Yu;J. Biol. Chem.,1999

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioanalytical Aspects in Biological Therapeutics;Bioanalytical Aspects in Biological Therapeutics;2022-07

2. Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases;Cell Death & Disease;2022-03-17

3. Multimodal analysis for human ex vivo studies shows extensive molecular changes from delays in blood processing;iScience;2021-05

4. TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease;Current Drug Targets;2021-04-26

5. Multimodal Analysis for Human ex vivo Studies Shows Extensive Molecular Changes from Delays in Blood Processing;2020-10-19